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Abstract
Objectives: Coeliac disease has emerged as an increasingly recognised public health problem over the last half-century, and
is now coming to be seen as a global phenomenon, despite a profound lack of globally representative epidemiological data.
Since children with coeliac disease commonly present with chronic diarrhoea and malnutrition, diagnosis is often
overlooked, particularly in poorer settings where children often fail to thrive and water-borne infectious diarrhoeas are
common. This is the first attempt to make global estimates of the burden of coeliac disease in childhood.
Methods: We built a relatively crude model of childhood coeliac disease, incorporating estimates of population prevalence,
probability of non-diagnosis, and likelihood of mortality among the undiagnosed across all countries from 1970 to 2010,
based around the few available data. All our assumptions are stated in the paper and the model is available as a
supplementary file.
Findings: Our model suggests that in 2010 there were around 2.2 million children under 5 years of age living with coeliac
disease. Among these children there could be 42,000 deaths related to coeliac disease annually. In 2008, deaths related to
coeliac disease probably accounted for approximately 4% of all childhood diarrhoeal mortality.
Conclusions: Although coeliac disease may only account for a small proportion of diarrhoeal mortality, these deaths are not
preventable by applying normal diarrhoea treatment guidelines, which may even involve gluten-based food supplements.
As other causes of diarrhoeal mortality decline, coeliac disease will become a proportionately increasing problem unless
consideration is given to trying gluten-free diets for children with chronic diarrhoea and malnutrition.
Citation: Byass P, Kahn K, Ivarsson A (2011) The Global Burden of Childhood Coeliac Disease: A Neglected Component of Diarrhoeal Mortality? PLoS ONE 6(7):
e22774. doi:10.1371/journal.pone.0022774
Editor: Antje Timmer, Ludwig Maximilian University of Munich, Germany
Received January 11, 2011; Accepted July 7, 2011; Published July 26, 2011
Copyright:  2011 Byass et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was undertaken within the Umea ˚ Centre for Global Health Research, with support from FAS, the Swedish Council for Working Life and Social
Research (grant no. 2006-1512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: peter.byass@epiph.umu.se
Introduction
Over the last half-century, research has increasingly revealed
the nature and extent of coeliac disease, particularly among
European populations, but there remains much to be learnt about
this disease on a global scale [1–3]. Coeliac disease is a systemic
autoimmune syndrome involving a gluten-induced chronic
inflammation of the small bowel mucosa, with extensive short-
and long term negative health consequences if untreated [4].
Symptomatology can vary for an individual over time, and often
mimics other diseases, which, combined with low global awareness
of the disease, results in many cases remaining undiagnosed or
being ineffectively treated. Examples of signs and symptoms are
malabsorption with diarrhoea and consequent under-nutrition,
short stature, anaemia, stomach pain, and increased incidence of
many infectious diseases. The disease is effectively treated by life-
long exclusion of all foods containing any amount of gluten-
bearing cereals (wheat, rye or barley), while all other foods,
including principal components of staple diets in many societies
such as rice and maize, are completely safe. Adopting a gluten-free
diet, either following clinical diagnosis or in response to symptoms,
resolves coeliac disease enteropathy, and thereby eliminates
associated health risks. Thus, from a public health perspective,
the at-risk group comprises those living with coeliac disease that is
not diagnosed as such.
The sporadic data that do exist from Africa, Asia and Latin
America indicate that coeliac disease is by no means confined to
European populations [3,5–15]. In contrast, we were unable to
find any reports of populations free from coeliac disease. A recent
study of worldwide in-migrants to Sweden also showed that non-
European ethnicities were susceptible to coeliac disease but at rates
ranging from 41% to 125% of that of the native population [16].
As part of globalisation, regular consumption of foods containing
wheat is becoming increasingly common, even in traditionally
maize or rice-consuming societies, possibly leading to an increased
burden of coeliac disease. Wheat is also commonly supplied by
international food aid programmes. Wheat consumption data for
2000 showed that the Middle East and Western Europe had the
highest levels (147 kg/person/year and 102 kg/person/year
respectively), while other regions were closer to 60 kg/person/
year [17]. Even in Europe, where coeliac disease was first
recognised in the mid-20
th century, data from community-based
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remain far from complete [3,9,18,19] though they are improving
over time [20]. In settings where diarrhoeal infections remain as
common causes of childhood morbidity and mortality, it is not
difficult to postulate that coeliac disease is a cause that can easily
escape attention [5]. At the same time it is reasonable to suppose
that continuing non-diagnosis may well lead to severe illness and
death in affected children, despite symptomatic treatments such as
oral rehydration fluids, nutritional supplements (possibly contain-
ing gluten) and antibiotics [21]. Inevitably there are very few data
on the mortality risk of undiagnosed coeliac disease, but one
historical study from the USA estimates a four-fold risk [22].
Historic data (from before the discovery of gluten-free diet for
managing coeliac disease) from the United Kingdom [23]
suggested a childhood case-fatality rate of up to 30% in the
1930s, when mortality between the ages of 1 and 5 years was
around 3% (www.mortality.org), suggesting a mortality risk of up
to 10.
This combination of factors around coeliac disease and its
under-diagnosis has led us to consider how much it might
contribute to the global burden of childhood morbidity and
mortality. Since the global data are very sparse, at this stage the
only option was to model estimates of what numbers may be
involved and in which regions of the world the consequences may
be greatest. Making global estimates of this kind is a somewhat
fraught process, and findings need to be handled with care [24].
Inevitably this process has involved making a number of
assumptions which could well be contested, but our aim in this
paper is to set out our reasoning and findings in a transparent
fashion, accompanied by a supplementary file containing our
detailed data and results, so that at least the possible global burden
of childhood coeliac disease can be further debated and
investigated.
Methods
As a starting point we have taken established national estimates
of under-5 population and mortality for the entire world from
1970 to 2010 [25,26], remembering that such estimates are
themselves under frequent revision and update [27]. In addition
recent estimates of child mortality for 2008 give specific country
data for diarrhoeal deaths [28]. Different sources of various
estimates use a multiplicity of regional groupings of countries, and
we have chosen to follow the WHO regional groupings for the
sake of widespread comparability, even though this contains some
geographical inconsistencies such as, for example, the political
necessity to have the Republic of Korea and adjoining Democratic
People’s Republic of Korea in different regions. The WHO
regions are illustrated in Figure 1.
Since data on population prevalences of coeliac disease are very
limited or non-existent for many countries, we had to make
relatively crude assumptions about regional prevalence rates, as
also shown in Figure 1, based on known point-prevalence
estimates, taking 1% except for Africa, South-east Asia and the
Western Pacific, which were taken as 0.33% [3,5–16]. The 1%
value is within the typical range of population-based measure-
ments, where these have been made; the 0.33% value for Africa
and South-East Asia was chosen as a more conservative estimate
given the general lack of data from those areas but some evidence
of lower disease prevalence than elsewhere.
The second area in which major assumptions were needed was
the extent of non-diagnosis of coeliac disease at different times and
places, conceptualised in equation (I) as the probability of an
individual with coeliac disease being undiagnosed in a particular
time and context:
Pr non-diagnosis ðÞ ~
f time ðÞ zf health service performance ðÞ zconstant
ðIÞ
In 1970, at the start of the period covered by the data used here,
awareness of coeliac disease was not widespread and throughout
the world probabilities of non-diagnosis were high [19,29]. This
has gradually changed over time, but it is still reasonable to assume
that settings with relatively basic health services have only
progressed slowly with respect to rates of coeliac disease diagnosis.
Although WHO has worked with an index of health service
performance, this is not available with variations by country and
time [30]. Since there is no absolute global measure of health
service performance over time, we have used national cumulative
under-5 mortality proportions by year and country as a proxy.
Hence we have developed the general statement of equation (I)
into more specific terms in equation (II):
Pr non{diagnosis ðÞ y,c~
2015{y ðÞ =100 ½  z H proportion dying under{5 ðÞ y,c
hi
z0:4
ðIIÞ
Figure 1. World map by WHO Regions, as used as the basis for modelled estimates, showing underlying assumptions about the
population prevalence of childhood coeliac disease.
doi:10.1371/journal.pone.0022774.g001
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with a capped value of 1.
It then follows (equation III) that the number of children with
undiagnosed coeliac disease can be estimated for each year y and
country c as:
N undiagnosed ðÞ y,c~N under-5population ðÞ y,c
|Pr non-diagnosis ðÞ y,c|prevalencec
ðIIIÞ
The third major assumption concerns the relative risk of
mortality for children with undiagnosed coeliac disease compared
to children in general in the same country and year. There are by
definition hardly any data available for this, but we considered it
reasonable to assume that it would be related to the annual
probability of all-cause deaths for children between 1 and 4 years
of age (annual 5q1) for a particular year y and country c, and we
have taken a relative risk (RR) of 5, which is also close to the one
published estimate of mortality risk [22]. By excluding infancy, this
assumption avoids the potentially distorting effect of variations in
neonatal and infant mortality. Thus the annual numbers (N) of
childhood deaths attributable to undiagnosed coeliac disease was
estimated for each year y and country c according to equation
(IV):
N coeliac deaths ðÞ y,c~
N undiagnosed cases ðÞ y,c| annual 5q1 ðÞ y,c|RR
ðIVÞ
It then follows that the case-fatality rate (CFR) for undiagnosed
coeliac disease can be estimated from equation (V) for each year y
and country c as:
CFRy,c~N coeliac deaths ðÞ y,c
.
N undiagnosed cases ðÞ y,c ðVÞ
and the cause-specific mortality rate (CSMR) for coeliac disease
per 1,000 children at the population level can be estimated from
equation (VI) as:
CSMRy,c~1000|N coeliac deaths ðÞ y,c
.
N under-5population ðÞ y,c ðVIÞ
Data were managed using Microsoft FoxPro v9 and analysed
using Stata v10, and the detailed data by year and country are
presented in spreadsheet format as supplementary material
(Dataset S1).
Results
Results of the modelling by year and country are presented here
according to WHO regions. The complete by year and country
data are available in the supplementary file (Dataset S1) for
readers who may wish to classify countries in other ways. The
distributions of probabilities of non-diagnosis of childhood coeliac
disease over time and country, calculated according to equation
(II), are presented by region in Figure 2. These were then used to
calculate corresponding numbers of undiagnosed children accord-
ing to equation (III), which are shown by region in Figure 3.
Figure 4 shows the estimated number of under-5 deaths by region
attributable to coeliac disease, calculated according to equation
(IV). Global totals for 2010 amount to 2.2 million undiagnosed
children, of whom 42,000 may die annually (1.9%). Figures 5 and
6 show regional estimates over time for case fatality rates among
Figure 2. Scatter plots of probabilities of non-diagnosis of coeliac disease by country and year, grouped by WHO region. (AFRO
African region, EMRO Eastern Mediterranean region, EURO European region, PAHO Pan-American region, SEARO South-east Asian region, WPRO
Western Pacific region; as shown in Figure 1).
doi:10.1371/journal.pone.0022774.g002
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mortality rates for coeliac disease at the population level,
respectively, calculated according to equations (V) and (VI).
Estimates of the proportions of under-5 deaths attributable to
diarrhoea by country are available for 2008 from the CHERG
group [28]. These were used alongside our modelled results for
Figure 3. Estimated numbers of under-5 children with undiagnosed coeliac disease, by WHO region and year. (AFRO African region,
EMRO Eastern Mediterranean region, EURO European region, PAHO Pan-American region, SEARO South-east Asian region, WPRO Western Pacific
region; as shown in Figure 1).
doi:10.1371/journal.pone.0022774.g003
Figure 4. Estimated numbers of coeliac disease related under-5 deaths by WHO region and year. (AFRO African region, EMRO Eastern
Mediterranean region, EURO European region, PAHO Pan-American region, SEARO South-east Asian region, WPRO Western Pacific region; as shown
in Figure 1).
doi:10.1371/journal.pone.0022774.g004
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Eastern Mediterranean region, EURO European region, PAHO Pan-American region, SEARO South-east Asian region, WPRO Western Pacific region; as
shown in Figure 1).
doi:10.1371/journal.pone.0022774.g005
Figure 6. Estimates of coeliac disease related mortality rates in under-5 populations by WHO region and year. (AFRO African region,
EMRO Eastern Mediterranean region, EURO European region, PAHO Pan-American region, SEARO South-east Asian region, WPRO Western Pacific
region; as shown in Figure 1).
doi:10.1371/journal.pone.0022774.g006
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mortality that could have been coeliac-related during that year.
These results are shown in Figure 7. Globally these figures
amounted to 44,300 coeliac-related deaths out of 1.04 million
diarrhoea-related deaths (4.2%).
As identified above, there are three important areas in the
model where key assumptions had to be made: the population
prevalence of coeliac disease; the probability of non-diagnosis of
coeliac disease; and the relative risk of mortality associated with
undiagnosed coeliac disease, as well as uncertainties in the global
child mortality estimates used in our equations. We have
undertaken uncertainty and sensitivity analyses to reflect variations
in modelled outcomes accordingly. The global child mortality
estimates by year and country which are used in the model as
described above have well-established uncertainty bounds [28].
Reworking the model using low bounds and high bounds
respectively results in an uncertainty range from 36,000 to
49,000 around our estimate of 42,000 deaths in 2010 (approxi-
mately 615%). Since there is no reasonable evidence base for
constructing uncertainty bounds around our assumptions about
prevalence, non-diagnosis and case fatality, we have use a
sensitivity analysis approach to illustrate the effects of variations
in these parameters. Table 1 shows the results of sensitivity
analyses around these assumptions, based on overall figures of
undiagnosed children and deaths related to coeliac disease for
1990, 2000 and 2010.
Discussion
Our results suggest that coeliac disease is a neglected global
public health problem, contributing to avoidable morbidity and
mortality among young children. Based on the relatively
conservative estimates made in our model, around 2.2 million
children under five years of age today probably have undiagnosed
coeliac disease. Around 42,000 childhood deaths annually could
still be due to coeliac disease, despite in some of those children
diarrhoeal symptoms being treated according to WHO recom-
mendations, which as yet do not take into account the possibility of
some children needing a gluten-free diet to alleviate diarrhoea
[21].
Considering these results, and despite the scarcity of underlying
global data, it appears that coeliac disease represents an
appreciable global problem. We have had to make quite sweeping
assumptions to build the model, but as far as possible these are
based on such evidence as is actually available and are relatively
conservative compared with, for example, some high point-
prevalence measures [8,31]. The sensitivity analyses (presented in
Table 1) demonstrate that variations in our key assumptions have
approximately linear effects on output parameters, indicating a
rather stable model, and carrying the uncertainty bounds
associated with the global child mortality estimates through the
model had a relatively modest effect on the overall outcome. An
initial version of our model, built from the previous generation of
global mortality estimates, also gave rather similar overall findings
(data not shown), which constitutes another kind of indirect
sensitivity analysis.
Some of the assumptions that we have made in modelling these
estimates can certainly be challenged; one of our intentions in
publishing this model is precisely to stimulate such debate. Very
few data are available on the population-based prevalence of
coeliac disease in settings where childhood morbidity and
mortality arising from diarrhoea and malnutrition are common.
Our assumptions on global prevalence are well within the range of
known point-prevalence estimates. Regional variations in genetic
profiles and environmental and lifestyle factors, such as the age
when gluten-containing foods are introduced to infants and
possibly the amounts involved, probably contribute to variations
in coeliac disease prevalence [18]. However, at the moment this
Figure 7. Estimated under-5 diarrhoeal deaths in 2008 by WHO region, showing the estimated coeliac-related component (red bars
and numbers of cases). (AFRO African region, EMRO Eastern Mediterranean region, EURO European region, PAHO Pan-American region, SEARO
South-east Asian region, WPRO Western Pacific region; as shown in Figure 1).
doi:10.1371/journal.pone.0022774.g007
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global modelling. Non-diagnosis of children with classic symptoms
of coeliac disease is subjectively much more likely in settings where
diarrhoeal disease and malnutrition is common, which we believe
may be reasonably well captured by relating it to under-5
mortality as a proxy, although this may not capture local details
such as referral hospitals which may achieve higher rates of
diagnosis. Then it seems reasonable to assume that the risk of
mortality associated with undiagnosed coeliac disease is directly
related to childhood population mortality risks in the same
settings–the question being the extent of the relative risk. Clearly
there are no contemporary or future studies concerning the
relative mortality risk of non-diagnosis, though the limited
historical evidence suggests a relative risk of 5 is not unreasonable
[22,23] More empirical data from a wide geographic range are
clearly needed to confirm or revise the global basis of many of the
assumptions in our model; this is simply a starting point.
Closer examination of the model outputs suggests distinctly
different patterns and dynamics of coeliac disease in different
regions. Africa is the only region with a substantial continuing
growth in under-5 population, and these demographics mean that
any childhood disease in Africa may be subject to increase in
absolute terms unless countermeasures also become increasingly
effective (Figure 3). Since this growth is coupled with some of the
world’s least effective health services, the burden of childhood
mortality is likely to be high. It is not surprising therefore to see
that the present-day coeliac-related case fatality rate is by far the
highest in Africa (Figure 5).
Established guidelines in Europe for diagnosing coeliac disease
involves firstly analyses of serological markers (antihuman tissue
transglutaminase of isotype IgA), and, if these are elevated, a
secondary evaluation of a small bowel mucosal specimen to reveal
enteropathy, followed by normalisation of serological markers and
symptoms consequent upon a strict gluten-free diet. Although
coeliac disease has been mostly documented in industrialised
countries, it is important to note that our model suggests that its
biggest burden of morbidity and mortality falls in Africa and Asia.
Given the relatively basic nature of diagnostic facilities in these
settings, it is likely that relatively few cases will be definitively
diagnosed according to the above guidelines, and it may be
appropriate to develop public health strategies involving at least
temporary exclusion of dietary gluten (i.e. all wheat-based foods) as
presumptive diagnosis and management for children who present
with persistent diarrhoea, malnutrition or failure to thrive. In most
of Africa and Asia maize- and rice-based foods are relatively easily
available alongside wheat-based products, so that the provision of
special foods such as gluten-free bread and pasta are probably not
necessary. However, care needs to be taken in settings with high
HIV-prevalence and poor prevention of mother-to-child trans-
mission (PMTCT) programmes since diarrhoea, malnutrition and
failure to thrive is a common presenting clinical picture in
paediatric HIV/AIDS as well as in coeliac disease. There is no
population-based literature on interactions between HIV and
coeliac disease. Thus likely HIV infection should be excluded
before trying a gluten-free diet in such children so as not to further
compromise nutritional status or confuse nutritional messages
given to caregivers of HIV positive children.
It is curious to note that a recent major review of research
priorities on childhood diarrhoea [32] does not even mention
coeliac disease as a potential distinct cause of childhood diarrhoeal
deaths. Work on childhood diarrhoea from the Child Health
Epidemiology Reference Group (CHERG) also does not appear to
consider coeliac disease as a distinct aetiology for diarrhoea [33],
even though appreciable proportions of diarrhoeal disease are not
associated with specific aetiologies. If advances in preventing other
causes of diarrhoeal death were to be increasingly successful, then
one would have to assume that the proportion of coeliac-related
mortality out of all diarrhoeal causes would rise. It could thus
represent an increasingly large and intractable proportion of
global childhood diarrhoeal mortality in the future, in the absence
of increased awareness and better patient management strategies.
Recognising this also has implications for the distribution of wheat
as emergency food aid, particularly to malnourished children. It is
therefore very important in terms of public health strategy to
ensure that coeliac disease is put firmly onto the paediatric
diagnostic agenda on a global basis.
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Table 1. Sensitivity analyses for key estimates of coeliac-related morbidity and mortality, applied to numbers of undiagnosed
cases and deaths in 1990, 2000 and 2010.
Model parameter Model outputs (in 000s)
1990 2000 2010
cases deaths cases deaths cases deaths
Model as presented 3,062 86.1 2,560 60.5 2,211 41.9
1% prevalence globally 5,715 202.1 4,866 1,469 4,182 102.9
0.5% prevalence globally 2,857 101.1 2,433 734.5 2,091 51.5
Pr(non-diagnosis) q 50% 3,450 88.8 3,332 68.7 3,460 55.1
Pr(non-diagnosis) Q 50% 1,543 44.5 1,280 30.3 1,105 20.9
mortality relative risk q 50% 3,062 172.2 2,560 121.1 2,211 83.8
mortality relative risk Q 50% 3,062 43.1 2,560 30.3 2,211 21.0
doi:10.1371/journal.pone.0022774.t001
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